BMY:NYE-Bristol-Myers Squibb Company (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 58

Change

+0.24 (+0.42)%

Market Cap

USD 116.28B

Volume

4.69M

Analyst Target

USD 73.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

-1.53 (-0.19%)

USD 690.46B
NVO Novo Nordisk A/S

+0.28 (+0.32%)

USD 363.61B
JNJ Johnson & Johnson

-0.27 (-0.19%)

USD 347.83B
ABBV AbbVie Inc

-0.80 (-0.44%)

USD 310.27B
PFE Pfizer Inc

-0.18 (-0.67%)

USD 145.81B
OGN Organon & Co

+0.22 (+1.49%)

USD 3.94B
GSK GlaxoSmithKline PLC ADR

+0.09 (+0.26%)

N/A
MRK Merck & Company Inc

+0.42 (+0.42%)

N/A
NVS Novartis AG ADR

+0.05 (+0.05%)

N/A

ETFs Containing BMY

FHI:CA CI Health Care Giants Cov.. 6.22 % 0.75 %

N/A

CAD 0.08B
CAMX Cambiar Aggressive Value .. 4.77 % 0.00 %

+0.01 (+0.00%)

USD 0.06B
SCHD Schwab U.S. Dividend Equi.. 4.63 % 0.07 %

+0.01 (+0.00%)

USD 64.95B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.55 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.49 % 0.00 %

N/A

N/A
KNGU:CA Brompton U.S. Cash Flow K.. 4.47 % 0.00 %

N/A

CAD 6.54M
MEDX Horizon Kinetics Medical .. 4.15 % 0.00 %

+0.07 (+0.00%)

N/A
DIVP The Advisors’ Inner .. 3.76 % 0.00 %

+0.04 (+0.00%)

USD 0.01B
CDNA:CA CI Bio-Revolution Index E.. 3.71 % 0.00 %

N/A

CAD 6.05M
RUD:CA RBC Quant US Dividend Lea.. 3.20 % 0.43 %

N/A

CAD 0.69B
MHOT:AU VanEck Morningstar Wide M.. 3.11 % 0.00 %

N/A

N/A
SPHD Invesco S&P 500® High Di.. 3.03 % 0.30 %

+0.04 (+0.00%)

USD 3.40B
MOTV:LSE VanEck Morningstar US Wid.. 3.01 % 0.00 %

N/A

USD 0.05B
MOTU:LSE VanEck Morningstar US Wid.. 3.01 % 0.00 %

N/A

USD 0.05B
MOAT:AU VanEck Morningstar Wide M.. 2.98 % 0.00 %

N/A

USD 1.04B
HDCH:SW Invesco S&P 500 High Divi.. 2.92 % 0.00 %

N/A

USD 4.59M
TDIV:SW VanEck Morningstar Develo.. 2.90 % 0.00 %

N/A

USD 1.17B
TDGB:LSE VanEck Morningstar Develo.. 2.90 % 0.00 %

N/A

USD 1.16B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.89 % 0.00 %

N/A

USD 0.08B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
DHS:SW 2.39 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.39 % 0.00 %

N/A

N/A
SDOG ALPS Sector Dividend Dogs.. 2.36 % 0.40 %

+0.12 (+0.00%)

USD 1.18B
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.23 % 0.00 %

N/A

USD 0.01B
INCM:AU BetaShares Global Income .. 2.10 % 0.00 %

N/A

USD 0.03B
RSPH Invesco S&P 500 Equal Wei.. 2.03 % 0.00 %

+0.08 (+0.00%)

USD 0.88B
VALQ American Century STOXX U... 2.02 % 0.29 %

+0.15 (+0.00%)

USD 0.23B
LRND IQ U.S. Large Cap R&D Lea.. 2.02 % 0.00 %

+0.01 (+0.00%)

USD 7.90M
HEAL:SW iShares Healthcare Innova.. 2.01 % 0.00 %

N/A

N/A
ZLU:CA BMO Low Volatility US Equ.. 1.85 % 0.33 %

N/A

CAD 1.91B
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
UVDV 1.72 % 0.00 %

N/A

N/A
DIVG Invesco Exchange-Traded F.. 1.71 % 0.00 %

+0.07 (+0.00%)

USD 3.22M
ZUH:CA BMO Equal Weight US Healt.. 1.69 % 0.39 %

N/A

CAD 0.23B
JAVA JPMorgan Active Value ETF 1.63 % 0.00 %

+0.13 (+0.00%)

USD 2.46B
SPYD SPDR® Portfolio S&P 500 .. 1.54 % 0.08 %

+0.07 (+0.00%)

USD 6.71B
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

N/A

USD 0.04B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

N/A

USD 0.25B
SPXB 1.32 % 0.15 %

N/A

N/A
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

N/A

USD 0.15B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

N/A

N/A
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

N/A

USD 0.15B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

N/A

CAD 0.52B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

N/A

USD 0.09B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

N/A

USD 0.13B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

+0.26 (+0.00%)

USD 0.01B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

-0.27 (0.00%)

N/A
GBF iShares Government/Credit.. 0.00 % 0.20 %

+0.05 (+0.00%)

N/A
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

+0.26 (+0.00%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.41 (+0.00%)

N/A
PEY Invesco High Yield Equity.. 0.00 % 0.53 %

+0.10 (+0.00%)

USD 1.25B
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+0.27 (+0.00%)

N/A
PPH VanEck Pharmaceutical ETF 0.00 % 0.36 %

+0.15 (+0.00%)

USD 0.61B
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

+0.03 (+0.00%)

USD 1.62B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

-0.01 (0.00%)

USD 0.41B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.18 (+0.00%)

USD 0.02B
VSDA VictoryShares Dividend Ac.. 0.00 % 0.35 %

+0.09 (+0.00%)

USD 0.24B
HONR 0.00 % 0.65 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.01B
RUD-U:CA RBC Quant U.S. Dividend L.. 0.00 % 0.00 %

N/A

N/A
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.06 (0.00%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.06 (0.00%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

+0.10 (+0.00%)

USD 0.06B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.09B
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.01B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

N/A

USD 0.12B
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

N/A

USD 0.04B
MVUS:PA 0.00 % 0.00 %

N/A

N/A
SPMV:PA 0.00 % 0.00 %

N/A

N/A
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

N/A

N/A
VDIV:F VanEck Vectors ETFs N.V... 0.00 % 0.00 %

N/A

USD 0.64B
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 1.59M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.14B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 0.00 % 0.00 %

N/A

USD 0.13B
DXSP:XETRA Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

N/A

USD 0.05B
ETLI:XETRA L&G Pharma Breakthrough U.. 0.00 % 0.00 %

N/A

USD 0.02B
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.12B
VDIV:XETRA VanEck Morningstar Develo.. 0.00 % 0.00 %

N/A

USD 0.64B
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
REVS Columbia Research Enhance.. 0.00 % 0.00 %

+0.04 (+0.00%)

USD 0.06B
JSTC Tidal ETF Trust - Adasina.. 0.00 % 0.00 %

+0.08 (+0.00%)

USD 0.21B
LSAT Two Roads Shared Trust - .. 0.00 % 0.00 %

N/A

USD 0.12B
EDGE-U:CA Evolve Innovation Index F.. 0.00 % 0.00 %

N/A

N/A
AGNG Global X Aging Population.. 0.00 % 0.00 %

+0.12 (+0.00%)

USD 0.06B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

+0.02 (+0.00%)

USD 9.55M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.04% 80% B- 67% D+
Dividend Return 4.68% 80% B- 64% D
Total Return 17.72% 80% B- 69% C-
Trailing 12 Months  
Capital Gain 13.24% 80% B- 68% D+
Dividend Return 4.69% 80% B- 63% D
Total Return 17.92% 80% B- 70% C-
Trailing 5 Years  
Capital Gain -9.57% 33% F 39% F
Dividend Return 16.53% 56% F 55% F
Total Return 6.95% 22% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain -3.10% 20% F 19% F
Dividend Return 0.05% 20% F 21% F
Total Return 3.15% 60% D- 65% D
Risk Return Profile  
Volatility (Standard Deviation) 19.07% 50% F 57% F
Risk Adjusted Return 0.28% 20% F 21% F
Market Capitalization 116.28B 29% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.